Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Stamatoula Tsikrika (Athens, Greece), Stamatoula Tsikrika, Katerina Dimakou, Andriana Papaioannou, George Hillas, Kostantinos Kostikas, Stelios Loukides, Spyros Papiris, Nikos Koulouris, Petros Bakakos. Non-invasive evaluation of airway inflammation in non-CF bronchiectasis. Eur Respir J 2016; 48: Suppl. 60, 2556

Member's Comments

No comment yet.

Related content which might interest you: Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis Source: International Congress 2015 – Paediatric bronchology Year: 2015 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014 Eosinophilic versus non-eosinophilic COPD cannot be distinguished by lung function nor CT determined emphysema or airway remodelling Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Source: Eur Respir J 2008; 31: 396-406 Year: 2008 Airway inflammation markers in COPD Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 Modulation of Eosinophilic airway inflammation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Airway inflammation in cystic fibrosis Source: Eur Respir Monogr 2014; 64: 14-31 Year: 2014 Sputum processing methods in airway disease: Which is best? Source: International Congress 2014 – Airway biomarkers Year: 2014 The EvA-Study: Markers of emphysema versus airway disease in COPD Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC Year: 2009 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Management of bronchial inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Maximal ventilatory pressure and pulmonary function in subjects with non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008